Zhao Long Gong
Chief Executive Officer at 3D MEDICINES INC.
Net worth: 30 M $ as of 2024-05-30
Profile
Zhao Long Gong is the Chairman & Chief Executive Officer and founder of 3D Medicines, Inc. which is founded in 2014.
He is currently an Independent Director at Shanghai Innostar Biotechnology Co., Ltd.
since 2021.
Dr. Gong was previously an Independent Director at Shandong Jincheng Pharmaceutical Group Co., Ltd.
and Staidson (Beijing) Biopharmaceuticals Co., Ltd.
from 2015 to 2021.
Dr. Gong received his doctorate degree from New York University in 1996 and his undergraduate and graduate degrees from Peking University Health Science Center.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
3D MEDICINES, INC.
13.94% | 2024-04-04 | 35,992,364 ( 13.94% ) | 30 M $ | 2024-05-30 |
Zhao Long Gong active positions
Companies | Position | Start |
---|---|---|
3D MEDICINES INC. | Chief Executive Officer | 2013-12-31 |
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Director/Board Member | 2021-08-12 |
Former positions of Zhao Long Gong
Companies | Position | End |
---|---|---|
SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD | Director/Board Member | 2023-05-11 |
STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD. | Director/Board Member | 2021-08-10 |
Training of Zhao Long Gong
New York University | Doctorate Degree |
Peking University Health Science Center | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD. | Health Technology |
SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD | Health Technology |
3D MEDICINES INC. | Health Technology |
Private companies | 1 |
---|---|
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Commercial Services |
- Stock Market
- Insiders
- Zhao Long Gong